Patents by Inventor Masaki Shibayama
Masaki Shibayama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240121637Abstract: A wireless communication monitoring system for monitoring a hardware failure of a wireless communication unit of a wireless communication device using a remote monitoring control device, in which the wireless communication device transmits or receives a predetermined radio signal to or from a monitoring device added or attached to the host device to perform a life and death check for checking an operation, and the remote monitoring control device detects a hardware failure of the wireless communication unit of the wireless communication device on the basis of a result of the life and death check received from the wireless communication device. This makes it possible to detect a failure that cannot be detected from information obtained from a device state request to a wireless communication device of the related art.Type: ApplicationFiled: February 17, 2021Publication date: April 11, 2024Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATIONInventors: Akira MATSUSHITA, Mitsuru NISHINO, Munehiro MATSUI, Masaki SHIMA, Koichi HARADA, Hiroki SHIBAYAMA, Fumihiro YAMASHITA
-
Patent number: 11947140Abstract: A suction method is provided as a method of performing, by using a suction collet, suction of a Fabry-Perot interference filter including a substrate and a laminated structure that is provided on the substrate and that includes a main surface facing the side opposite to the substrate, the method including a first step of arranging the suction collet so as to face the main surface, a second step of bringing the suction collet into contact with the Fabry-Perot interference filter after the first step, and a third step of suctioning the Fabry-Perot interference filter by using the suction collet after the second step.Type: GrantFiled: November 9, 2018Date of Patent: April 2, 2024Assignee: HAMAMATSU PHOTONICS K.K.Inventors: Masaki Hirose, Katsumi Shibayama, Takashi Kasahara, Toshimitsu Kawai, Hiroki Oyama, Yumi Kuramoto
-
Publication number: 20240097344Abstract: A reflector antenna includes: a radiator that radiates a radio wave; a main reflector that reflects the radio wave radiated from the radiator in a communication direction; an expansion panel that is attached to at least a part of the main reflector to increase an area of the main reflector; and a first adjustment unit that changes a position of the radiator, or a second adjustment unit that replaces the radiator with a radiator having a different radiation angle. This configuration makes it possible to implement a large-aperture antenna having excellent transportability and operability without preparing another antenna having a large aperture and replacing a standard antenna.Type: ApplicationFiled: December 3, 2020Publication date: March 21, 2024Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATIONInventors: Koichi HARADA, Masaki SHIMA, Hiroki SHIBAYAMA, Fumihiro YAMASHITA
-
Patent number: 10184109Abstract: Disclosed is a method for obtaining differentiated cells and/or differentiated cell products, including the steps of: introducing undifferentiated cells into a perfused organ or living tissue; subjecting the undifferentiated cells introduced to perfusion culture together with the organ or living tissue so as to allow the undifferentiated cells to differentiate, thereby obtaining differentiated cells and/or differentiated cell products; collecting a perfusion culture solution that contains the resulting differentiated cells and/or differentiated cell products; and obtaining the differentiated cells and/or differentiated cell products contained in the collected perfusion culture solution.Type: GrantFiled: March 30, 2015Date of Patent: January 22, 2019Assignee: SYSMEX CORPORATIONInventors: Eiji Kobayashi, Toshiyuki Sato, Kenji Akama, Nobuyasu Hori, Masaki Shibayama, Yuki Aihara, Masakazu Kadowaki
-
Publication number: 20150275176Abstract: Disclosed is a method for obtaining differentiated cells and/or differentiated cell products, including the steps of: introducing undifferentiated cells into a perfused organ or living tissue; subjecting the undifferentiated cells introduced to perfusion culture together with the organ or living tissue so as to allow the undifferentiated cells to differentiate, thereby obtaining differentiated cells and/or differentiated cell products; collecting a perfusion culture solution that contains the resulting differentiated cells and/or differentiated cell products; and obtaining the differentiated cells and/or differentiated cell products contained in the collected perfusion culture solution.Type: ApplicationFiled: March 30, 2015Publication date: October 1, 2015Applicant: SYSMEX CORPORATIONInventors: Eiji KOBAYASHI, Toshiyuki SATO, Kenji AKAMA, Nobuyasu HORI, Masaki SHIBAYAMA, Yuki AIHARA, Masakazu KADOWAKI
-
Patent number: 8921114Abstract: A diagnosis support system for cancer is disclosed that comprises: a measurement value acquiring section for acquiring a measurement value of a first cancer patient; a sample data memory for storing sample data of a plurality of cancer patients different from the first patient; a reference range determination section for determining a reference range based on the measurement value of the first cancer patient; a display unit; and a display controller for controlling the display unit to display a diagnosis support screen showing the clinical information included in the sample data having measurement value within the reference range. A method of providing cancer diagnosis support information and a computer program product are also disclosed.Type: GrantFiled: August 25, 2008Date of Patent: December 30, 2014Assignee: Sysmex CorporationInventors: Hideki Ishihara, Tomoko Matsushima, Masaki Shibayama
-
Patent number: 8583588Abstract: A method for judging a risk of cancer recurrence comprising: acquiring an activity value and expression level of a first cyclin dependent kinase (CDK) of a cell contained in tissues extracted from cancer patients, an activity value and expression level of a second CDK, and a number of Ki67-expressing cells or an expression level of Ki67; and judging a risk of cancer recurrence based on the acquired activity value and expression level of the first CDK, the activity value and expression level of the second CDK, and a percentage of Ki67-expressing cells or the expression level of Ki67. A computer program product and a computer system are also disclosed.Type: GrantFiled: March 29, 2011Date of Patent: November 12, 2013Assignee: Sysmex CorporationInventors: Masaki Shibayama, Hideki Ishihara, Keigo Gohda, Satoshi Nakayama, Tadashi Kiniwa
-
Patent number: 8160821Abstract: A method of supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs is disclosed. The method provides a new value for judging an effect, a judgment score, which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The effect of the treatment by using anthracycline anticancer drugs is judged by comparing the judgment score with a predetermined threshold level.Type: GrantFiled: September 30, 2008Date of Patent: April 17, 2012Assignee: Sysmex CorporationInventors: Masaki Shibayama, Hideki Ishihara, Tomoko Matsushima, Shigehiro Numada
-
Patent number: 8041514Abstract: A method for judging feature of malignant tumor is described. The method comprises obtaining step, first comparing step, second comparing step and judging step. The obtaining step comprises obtaining a first parameter based on activity and expression level of a first cyclin dependent kinase (first CDK) contained in a tumor cell of the malignant tumor, a second parameter based on activity and expression level of a second cyclin dependent kinase (second CDK) contained in the tumor cell, a third parameter based on the first parameter and the second parameter, and a fourth parameter based on expression level of a cyclin contained in the tumor cell. The first comparing step comprises comparing a first threshold value with the third parameter. The second comparing comprises comparing a second threshold value with the fourth parameter. The judging step comprises judging the feature of the malignant tumor based on the comparison results of the first comparing step and the second comparing step.Type: GrantFiled: February 27, 2007Date of Patent: October 18, 2011Assignee: Sysmex CorporationInventors: Satoshi Tanaka, Masaki Shibayama, Hideki Ishihara, Tomoko Matsushima, Aya Katayama, Yuko Kawasaki
-
Publication number: 20110246413Abstract: A method for judging a risk of cancer recurrence comprising: acquiring an activity value and expression level of a first cyclin dependent kinase (CDK) of a cell contained in tissues extracted from cancer patients, an activity value and expression level of a second CDK, and a number of Ki67-expressing cells or an expression level of Ki67; and judging a risk of cancer recurrence based on the acquired activity value and expression level of the first CDK, the activity value and expression level of the second CDK, and a percentage of Ki67-expressing cells or the expression level of Ki67. A computer program product and a computer system are also disclosed.Type: ApplicationFiled: March 29, 2011Publication date: October 6, 2011Applicant: SYSMEX CORPORATIONInventors: Masaki SHIBAYAMA, Hideki Ishihara, Keigo Gohda, Satoshi Nakayama, Tadashi Kiniwa
-
Publication number: 20110244497Abstract: The present invention provides a method for judging susceptibility of cancer cells contained in a biological sample to an anthracycline anticancer agent comprising steps of: measuring expression levels of GST-? of cancer cells contained in a biological sample; and judging the susceptibility of cancer cells contained in a biological sample to an anthracycline anticancer agent as high when the expression level of GST-? obtained by the measuring process is high, and a computer program which makes a computer execute the method.Type: ApplicationFiled: March 30, 2011Publication date: October 6, 2011Applicant: SYSMEX CORPORATIONInventors: Tomoko Ohyama, Masaki Shibayama, Hideki Ishihara, Tomokazu Yoshida, Keigo Gohda
-
Patent number: 8014960Abstract: A method of supporting a diagnosis of a risk of cancer recurrence is disclosed. The method provides a new determining value a recurrence risk score (RRS) which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The risk of cancer recurrence is judged by comparing the RRS with a predetermined threshold level for RRS.Type: GrantFiled: September 30, 2008Date of Patent: September 6, 2011Assignee: Sysmex CorporationInventors: Masaki Shibayama, Hideki Ishihara, Tomoko Matsushima, Shigehiro Numada
-
Publication number: 20100250483Abstract: An effect predicting apparatus for predicting an effect of anthracycline anticancer drugs, comprising: a display, a processor, and a memory, under control of said processor, including software instructions adapted to enable the processor to perform operations, comprising: acquiring a CDK parameter based on a first CDK parameter and a second CDK parameter; acquiring an expression level of glutathione; comparing the CDK parameter with a CDK threshold value, and the expression level of glutathione with a glutathione threshold value; predicting an effect of anthracycline anticancer drugs based on the result of the comparison; and displaying the result of the prediction. A computer program product and a method for predicting an effect are also disclosed.Type: ApplicationFiled: September 29, 2009Publication date: September 30, 2010Applicant: SYSMEX CORPORATIONInventors: Tomoko Ohyama, Masaki Shibayama, Hideki Ishihara, Tomokazu Yoshida, Keigo Gohda
-
Publication number: 20090246809Abstract: A method of supporting a diagnosis of a risk of cancer recurrence is disclosed. The method provides a new determining value a recurrence risk score (RRS) which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The risk of cancer recurrence is judged by comparing the RRS with a predetermined threshold level for RRS.Type: ApplicationFiled: September 30, 2008Publication date: October 1, 2009Applicant: SYSMEX CORPORATIONInventors: Masaki Shibayama, Hideki Ishihara, Tomoko Matsushima, Shigehiro Numada
-
Publication number: 20090248316Abstract: A method of supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs is disclosed. The method provides a new value for judging an effect, a judgment score, which is calculated based on expression levels and activity values of two cyclin dependent kinases (CDKs). The effect of the treatment by using anthracycline anticancer drugs is judged by comparing the judgment score with a predetermined threshold level.Type: ApplicationFiled: September 30, 2008Publication date: October 1, 2009Applicant: SYSMEX CORPORATIONInventors: Masaki Shibayama, Hideki Ishihara, Tomoko Matsushima, Shigehiro Numada
-
Publication number: 20090054739Abstract: A diagnosis support system for cancer is disclosed that comprises: a measurement value acquiring section for acquiring a measurement value of a first cancer patient; a sample data memory for storing sample data of a plurality of cancer patients different from the first patient; a reference range determination section for determining a reference range based on the measurement value of the first cancer patient; a display unit; and a display controller for controlling the display unit to display a diagnosis support screen showing the clinical information included in the sample data having measurement value within the reference range. A method of providing cancer diagnosis support information and a computer program product are also disclosed.Type: ApplicationFiled: August 25, 2008Publication date: February 26, 2009Applicant: SYSMEX CORPORATIONInventors: Hideki ISHIHARA, Tomoko Matsushima, Masaki Shibayama
-
Publication number: 20070202555Abstract: A method for judging feature of malignant tumor is described. The method comprises obtaining step, first comparing step, second comparing step and judging step. The obtaining step comprises obtaining a first parameter based on activity and expression level of a first cyclin dependent kinase (first CDK) contained in a tumor cell of the malignant tumor, a second parameter based on activity and expression level of a second cyclin dependent kinase (second CDK) contained in the tumor cell, a third parameter based on the first parameter and the second parameter, and a fourth parameter based on expression level of a cyclin contained in the tumor cell. The first comparing step comprises comparing a first threshold value with the third parameter. The second comparing comprises comparing a second threshold value with the fourth parameter. The judging step comprises judging the feature of the malignant tumor based on the comparison results of the first comparing step and the second comparing step.Type: ApplicationFiled: February 27, 2007Publication date: August 30, 2007Applicant: SYSMEX CORPORATIONInventors: Satoshi Tanaka, Masaki Shibayama, Hideki Ishihara, Tomoko Matsushima, Aya Katayama, Yuko Kawasaki